Related references
Note: Only part of the references are listed.Cognitive behavioral therapy for depression and anxiety of Parkinson's disease: A systematic review and meta-analysis
Qi Zhang et al.
COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE (2020)
A call for better depression treatment in people with Parkinson disease
Gregory M. Pontone et al.
NEUROLOGY (2020)
Telephone-based cognitive behavioral therapy for depression in Parkinson disease A randomized controlled trial
Roseanne D. Dobkin et al.
NEUROLOGY (2020)
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults
Donna M. Fick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Impulse control disorders in Parkinson's disease: A 20-year odyssey
Daniel Weintraub
MOVEMENT DISORDERS (2019)
Predictors of health-related quality of life in Parkinson's disease
Greg D. Kuhlman et al.
PARKINSONISM & RELATED DISORDERS (2019)
Update of the MDS research criteria for prodromal Parkinson's disease
Sebastian Heinzel et al.
MOVEMENT DISORDERS (2019)
Suicide in Parkinson's disease
Melissa Deanna Shepard et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease
Gregory M. Pontone et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease
Gregory M. Pontone et al.
NPJ PARKINSONS DISEASE (2019)
Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis
Kelly A. Mills et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality
Jared T. Hinkle et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Clinical Markers of Anxiety Subtypes in Parkinson Disease
Martinus P. G. Broen et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2018)
Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats
Cheng Xue Du et al.
NEUROLOGICAL RESEARCH (2018)
Activation and blockade of basolateral amygdala 5-HT6 receptor produce anxiolytic-like behaviors in an experimental model of Parkinson's disease
Yi-Na Sun et al.
NEUROPHARMACOLOGY (2018)
Association between depression and the subsequent risk of Parkinson's disease: A meta-analysis
Shun Wang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Roberta Balestrino et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease
Marina Picillo et al.
PARKINSONISM & RELATED DISORDERS (2017)
Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes A Systematic Review With Network Meta-analysis
Andre R. Brunoni et al.
JAMA PSYCHIATRY (2017)
The longitudinal impact of depression on disability in Parkinson disease
Gregory M. Pontone et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
Gretchen O. Reynolds et al.
MOVEMENT DISORDERS (2016)
Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care
Jacob Taylor et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)
The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants
Kenneth Lee et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2016)
Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis
Martijn P. G. Broen et al.
MOVEMENT DISORDERS (2016)
Depression and anxiety are co-morbid but dissociable in mild Parkinson's disease: A prospective longitudinal study of patterns and predictors
Natalie Wee et al.
PARKINSONISM & RELATED DISORDERS (2016)
Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations
Anna Borisovskaya et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2016)
Risk of Parkinson's disease following anxiety disorders: a nationwide population-based cohort study
C. -H. Lin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
Javier Pagonabarraga et al.
LANCET NEUROLOGY (2015)
Activation of 5-HT1A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease
Yi-Na Sun et al.
NEUROPHARMACOLOGY (2015)
Treating Anxiety Disorders in Older Adults: Current Treatments and Future Directions
Emily S. Bower et al.
HARVARD REVIEW OF PSYCHIATRY (2015)
Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration
Silvana Borges et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Effects of tDCS on executive function in Parkinson's disease
Deniz Doruk et al.
NEUROSCIENCE LETTERS (2014)
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease
A. J. H. Moonen et al.
PARKINSONISM & RELATED DISORDERS (2014)
Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease
Atami Sagna et al.
PARKINSONISM & RELATED DISORDERS (2014)
Pharmacologic Treatment of Anxiety Disorders in Parkinson Disease
Gregory M. Pontone et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2013)
Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial
Daniel Weintraub et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease
Bernd Mueller et al.
PARKINSONISM & RELATED DISORDERS (2013)
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
Vikas Kotagal et al.
ANNALS OF NEUROLOGY (2012)
Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease
Katrina L. Paumier et al.
MOVEMENT DISORDERS (2012)
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
I. H. Richard et al.
NEUROLOGY (2012)
Anxiety and self-perceived health status in Parkinson's disease
Gregory M. Pontone et al.
PARKINSONISM & RELATED DISORDERS (2011)
The Impact of Left Prefrontal Repetitive Transcranial Magnetic Stimulation on Depression in Parkinson's Disease: a Randomized, Double-Blind, Placebo-Controlled Study
Endre Pal et al.
MOVEMENT DISORDERS (2010)
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease A Randomized Controlled Trial
Frances M. Weaver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Course of Depressive Symptoms in Early Parkinson's Disease
Bernard Ravina et al.
MOVEMENT DISORDERS (2009)
A controlled trial of antidepressants in patients with Parkinson disease and depression
M. Menza et al.
NEUROLOGY (2009)
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinsons disease
Valerie Voon et al.
BRAIN (2008)
Anxiety and depression: Main determinants of health-related quality of life in Brazilian patients with Parkinson's disease
Francisco Javier Carod-Artal et al.
PARKINSONISM & RELATED DISORDERS (2008)
A systematic review of prevalence studies of depression in Parkinson's disease
Jennifer S. A. M. Reijnders et al.
MOVEMENT DISORDERS (2008)
Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study
DT Wade et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Share Paper
